These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34204146)

  • 21. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocytes are involved in the balance between regulatory T cells and Th17 cells in severe drug eruptions.
    Ushigome Y; Mizukawa Y; Kimishima M; Yamazaki Y; Takahashi R; Kano Y; Shiohara T
    Clin Exp Allergy; 2018 Nov; 48(11):1453-1463. PubMed ID: 30112775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9-year experience in a tertiary care paediatric hospital setting.
    Liccioli G; Mori F; Parronchi P; Capone M; Fili L; Barni S; Sarti L; Giovannini M; Resti M; Novembre EM
    Clin Exp Allergy; 2020 Jan; 50(1):61-73. PubMed ID: 31608511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.
    Bellón T
    Drug Saf; 2019 Aug; 42(8):973-992. PubMed ID: 31020549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review of BRAF/MEK inhibitors-induced Severe Cutaneous Adverse Reactions (SCARs).
    Torres-Navarro I; de Unamuno-Bustos B; Botella-Estrada R
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):607-614. PubMed ID: 32846030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions.
    Gibson A; Deshpande P; Campbell CN; Krantz MS; Mukherjee E; Mockenhaupt M; Pirmohamed M; Palubinsky AM; Phillips EJ
    J Allergy Clin Immunol; 2023 Feb; 151(2):289-300.e4. PubMed ID: 36740326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
    Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
    Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.
    Sukasem C; Pratoomwun J; Satapornpong P; Klaewsongkram J; Rerkpattanapipat T; Rerknimitr P; Lertpichitkul P; Puangpetch A; Nakkam N; Konyoung P; Khunarkornsiri U; Disphanurat W; Srisuttiyakorn C; Pattanacheewapull O; Kanjanawart S; Kongpan T; Chumworathayi P; Saksit N; Bruminhent J; Tassaneeyakul W; Chantratita W; Pirmohamed M
    Clin Pharmacol Ther; 2020 Nov; 108(5):1078-1089. PubMed ID: 32452529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and prognostic factors in severe cutaneous drug reactions.
    Yang MS; Kang MG; Jung JW; Song WJ; Kang HR; Cho SH; Min KU
    Int Arch Allergy Immunol; 2013; 162(4):346-54. PubMed ID: 24193402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
    J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of Severe Cutaneous Adverse Reactions.
    Yang SC; Chen CB; Lin MY; Zhang ZY; Jia XY; Huang M; Zou YF; Chung WH
    Front Med (Lausanne); 2021; 8():652091. PubMed ID: 34336873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?
    Bouvresse S; Valeyrie-Allanore L; Ortonne N; Konstantinou MP; Kardaun SH; Bagot M; Wolkenstein P; Roujeau JC
    Orphanet J Rare Dis; 2012 Sep; 7():72. PubMed ID: 23009177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.
    Godfrey H; Jedlowski P; Thiede R
    Australas J Dermatol; 2024 May; 65(3):243-253. PubMed ID: 38572842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective, 5-year, clinicoepidemiological study of severe cutaneous adverse reactions (SCARs).
    Singh GK; Mitra B; Arora S; Akhoon N; Verma R; Sharma P; Mitra D
    Int J Dermatol; 2021 May; 60(5):579-588. PubMed ID: 33454956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature.
    Casagranda A; Suppa M; Dehavay F; Del Marmol V
    Case Rep Dermatol; 2017; 9(2):1-7. PubMed ID: 28611628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines/Chemokines: Novel Biomarkers Associated with Severe Cutaneous Adverse Reactions.
    Zhang X; Lu WS; Qin XM
    J Interferon Cytokine Res; 2020 Apr; 40(4):172-181. PubMed ID: 32195616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs.
    Lee SY; Nam YH; Koh YI; Kim SH; Kim S; Kang HR; Kim MH; Lee JG; Park JW; Park HK; La HO; Kim MY; Park SJ; Kwon YE; Jung JW; Kim SH; Kim CW; Yang MS; Kang MG; Lee JY; Kim JH; Kim SH; Hur GY; Jee YK; Jin HJ; Park CS; Jeong YY; Ye YM
    Allergy Asthma Immunol Res; 2019 Mar; 11(2):212-221. PubMed ID: 30661313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
    Darlenski R; Kazandjieva J; Tsankov N
    Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe cutaneous adverse reactions in Asians: Trends observed in culprit anti-seizure medicines using VigiBase®.
    Shukla S; Rastogi S; Abdi SAH; Dhamija P; Kumar V; Kalaiselvan V; Medhi B
    Seizure; 2021 Oct; 91():332-338. PubMed ID: 34274893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.